Health economic evaluation alongside randomised clinical trial of a health behaviour intervention to manage type 2 diabetes in Nepal
2024

Cost-Effectiveness of a Health Behavior Intervention for Type 2 Diabetes in Nepal

Sample size: 481 publication 10 minutes Evidence: moderate

Author Information

Author(s): Padam Kanta Dahal, Zanfina Ademi, Lal Rawal, Mahumud Rashidul Alam, Grish Paudel, Biraj Karmacharya, Haruka Sakamoto, Tomohiko Sugishita, Corneel Vandelanotte

Primary Institution: Central Queensland University

Hypothesis

This study aimed to assess the within-trial economic evaluation of a health behaviour intervention compared with usual care for managing type 2 diabetes in a community setting in Nepal.

Conclusion

Health behaviour interventions in community settings are a cost-effective approach to manage type 2 diabetes, offering good value for money.

Supporting Evidence

  • The intervention yielded an incremental cost of US $28.55 per person.
  • The ICER associated with the health behaviour intervention was US $3,358.82 per QALY gained.
  • The intervention was cost-effective at the threshold of US $4,140.
  • Probabilistic sensitivity analysis indicated an 89.63% probability of cost-effectiveness.
  • Participants in the intervention group had a QALY gain of 0.0085 compared to the control group.

Takeaway

This study shows that helping people change their habits can be a smart way to manage diabetes without spending too much money.

Methodology

A cluster randomised control trial was conducted with 30 clusters and 481 patients, comparing a health behaviour intervention to usual care over 6 months.

Potential Biases

Self-reported data may introduce reporting bias.

Limitations

The study relied on short-term follow-up and was limited to two specific geographical locations in Nepal, which may affect generalizability.

Participant Demographics

Adults aged 30–70 years with type 2 diabetes, with a mix of genders and various occupations.

Statistical Information

P-Value

0.0085

Confidence Interval

95% CI = US $21.26 to US $35.84

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s41256-024-00364-z

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication